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Behçet’s disease is a chronic inflamm-atory disease diagnosed by recurrent aphth- ous ulcers, genital ulcers and eye involvement 
in the form of uveitis.1 Cerebrovascular involvement 
with arterial aneurysm rupture is an exceedingly 
rare phenomenon in patients with Behçet’s disease 
and is only found in 1.6–10% of all vascular lesions 
in these patients.2,3 Cerebral artery aneurysms, brain 
parenchymal inflammatory disease, pseudotumour 
cerebri, intimal hyperplasia of the cerebral artery 
and vasculitis are the main symptoms of neuro-
Behçet’s disease.4 Cardiac involvement leads to 
inflammatory endocardial disease, coronary artery 
stenosis, pericarditis, cardiomyopathy and thrombus 
formation.4 However, the combination of an intra-
cardiac thrombus with rupture of a cerebral artery 
aneurysm is a very rare occurrence.5 
Case Report 
A 35-year-old female known to have Behçet’s disease 
was referred to the Imam Ali Hospital, Kermanshah, 
Iran, in July 2014 from the neurosurgery ward for 
evaluation of postoperative dyspnoea. Seven days 
previously, she had undergone a cranial surgery for a 
ruptured cerebral artery aneurysm and the removal of 
parenchymal haemorrhagic lesions. Upon admission 
to the neurosurgery ward, an initial diagnosis of a 
ruptured cerebral artery aneurysm was made based 
on the parenchymal changes observed on computed 
tomography [Figure 1]. Cerebral angiography confirm-
ed haemorrhagic sequelae in the left cerebral artery 
branch due to the rupture of the aneurysm [Figure 2].
Seven days after the neurosurgery, the patient 
complained of vertigo, dysarthria, dyspnoea, fever, 
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abstract: We report a 35-year-old woman referred to the Imam Ali Hospital, Kermanshah, Iran, in July 2014 for 
evaluation of postoperative dyspnoea after neurosurgery performed seven days previously for a ruptured cerebral 
artery aneurysm. She was known to have Behçet’s disease with a history of recurrent oral and genital aphthous 
ulcers and uveitis. At referral, her symptoms included vertigo, dysarthria, palpitations and chest pain. Transthoracic 
echocardiography (TTE) revealed a large thrombus in her right ventricle outflow tract and open-heart surgery was 
performed eight days after the previous surgery to remove the clot. The postoperative period was complicated by 
transient acute renal failure, which resolved spontaneously. The patient was discharged 13 days after the cardiac 
surgery on warfarin, prednisolone, azathioprine and cyclophosphamide. Cyclophosphamide and azathioprine were 
discontinued after three months as the symptoms had completely resolved; however, prednisolone was continued 
due to recurrent uveitis. A 10-month follow-up TTE scan revealed no thrombus recurrence and treatment with 
warfarin and prednisolone was continued.
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امللخ�ص: هذا تقرير حالة لأمراأة تبلغ من العمر 35 عاما مت حتويلها اإىل م�ست�سفى الإمام علي، كرمان�ساه، اإيران، يف يوليو 2014 لتقييم 
�سيق التنف�س بعد اإجراء جراحة لتمدد �رسياين دماغي منفجر منذ �سبعة اأيام قبل التنومي.  كانت املري�سة م�سابة مبر�س بهجت مع تاريخ 
تلعثم،  دوار،  من  تعاين  املري�سة  كانت  التحويل  عند  القزحية.  والتهاب  التنا�سلية  والأع�ساء  الفم  يف  املتكررة  القالعية  للقرح  مر�سي  
وخفقان واأمل يف ال�سدر. ك�سف تخطيط �سدى القلب عرب ال�سدر )TTE( عن وجود جلطة كبرية يف تدفق جماري البطني الأمين. مت اإجراء 
جراحة قلب مفتوح بعد ثمانية اأيام من اجلراحة ال�سابقة. تعقدت فرتة ما بعد اجلراحة بحدوث الف�سل الكلوي احلاد، الذي �سفي من تلقاء 
نف�سه. غادرت املري�سة بعد 13 يوما من عملية القلب املفتوح على عقاقري الوارفارين، الربيدنيزولون، الآزوثيوبرين وال�سيكلوفو�سفاميد. مت 
ايقاف عقاري ال�سيكلوفو�سفاميد والآزوثيوبرين بعد ثالثة اأ�سهر نتيجة لأختفاء كل الأعرا�س متاما. ومع ذلك، ا�ستمر عقار الربيدنيزولون 
بالوارفارين  العالج  وا�ستمر  اجللطات  عودة  عن  �سهور  ع�رسة  بعد   TTE ال  فح�س  اعادة  تك�سف  مل  املتكررة.  القزحية  التهابات  ب�سبب 
والربيدنيزولون.
كلمات مفتاحية: مر�س بهجت؛ جلطة؛ متدد الأوعية الدموية املغزيل؛ تقرير حالة؛ اإيران.
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with 91% neutrophils; platelet count: 90,000/mm-3 
(NR: 150,000–450,000/mm-3); haemoglobin count: 
10 g/dL (NR: 13–18 g/dL); C-reactive protein levels: 
54 mg/dL (NR: ≤0.8 mg/dL); erythrocyte sedimentation 
rate: 80 mm/hour (NR: 0–20 mm/hour); blood urea 
nitrogen levels: 35 mg/dL (NR: 7–25 mg/dL); and 
creatinine levels: 2.9 mg/dL (NR: 0.6–1.2 mg/dL). The 
thrombocytopaenia was treated with prednisolone 
and her platelet levels had normalised when a repeat 
platelet count was performed three weeks later. 
Urinalysis revealed proteinuria without haematuria. 
Anti-nuclear, anti-neutrophil cytoplasmic, anti-double 
strand and anticardiolipin antibodies were negative, as 
were rheumatoid factor and lupus anticoagulants. Test 
results for other thrombophilia factors were normal, 
including hyperhomocysteinemia, antiphospholipid 
antibodies, protein S, protein C and antithrombin III 
levels and factor V Leiden. 
Transthoracic echocardiography (TTE) revealed 
a mobile thrombus in the right ventricle outflow tract 
(RVOT) of the subtricuspid apparatus [Figure 3]; 
this was believed to have been the cause of the 
patient’s respiratory symptoms. Eight days after the 
neurosurgery and one day after admission to the 
cardiac surgery ward, open cardiac surgery was 
performed to remove the clot. Intraoperatively, the 
thrombus was observed to be located in the RVOT 
with a single site of attachment to the perimembranous 
septum and septal tricuspid valve [Figure 4]. Surgical 
exploration of the pulmonary artery and its main 
branches revealed no other thrombi. A pulmonary 
thromboembolism was suspected; however, no facil-
ities for lung perfusion scans were available and the 
patient could not be transferred to another centre due 
to her general condition. 
Postoperatively, the patient suffered from acute 
renal dysfunction and nephrologists were consulted. 
heart palpitations and chest pain and was referred to 
the cardiac surgery ward. In the ward, her medical 
history revealed classic features of Behcet’s disease, 
including four occurrences of mouth and genital ulcers 
in the previous year and ophthalmologist-confirmed 
uveitis. A physical examination revealed signs of the 
former cranial surgery, multiple aphthous mouth and 
genital ulcers and left haemiparesis. There were no 
signs of thrombophlebitis or lower limb oedema. Chest 
radiography was normal. The results of laboratory tests 
on admission were as follows: white blood cell count: 
19,000/mm-3 (normal range [NR]: 4,300–10,800/mm-3) 
 
Figure 1: Preoperative computed tomography of 
a 35-year-old female patient with Behçet’s disease 
showing a haemorrhagic mass in the right cranial 
hemisphere (arrow) indicative of a ruptured cerebral 
artery aneurysm.
 
Figure 2: Postoperative cerebral angiography of a 
35-year-old female patient with Behçet’s disease with 
a ruptured cerebral artery aneurysm in the left middle 
cerebral artery branch (circle), with aneurysm clip in 
situ (arrow).
 
Figure 3: Transthoracic echocardiography of a 35-year-
old female patient with Behçet’s disease showing a large 
thrombus (arrows) in the right ventricular outflow tract.
LA = left atrium; RA = right atrium; LV = left ventricle; RV = right 
ventricle.
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However, the condition resolved spontaneously. 
A few days later, the patient was treated with 
immunosuppressive therapy for symptoms of Behcet’s 
disease. Symptoms of oral and genital aphthous ulcers 
and uveitis were relieved using a combination of 
oral corticosteroids, prednisolone, azathioprine and 
cyclophosphamide. Nine days after the cardiac surgery, 
she was prescribed anticoagulation therapy (heparin 
and warfarin) to prevent further thrombus formation. 
The patient was discharged on the 13th postoperative 
day on warfarin, prednisolone, azathioprine and 
cyclophosphamide. After three months of treatment, 
the cyclophosphamide and azathioprine were discont- 
inued due to resolution of the symptoms. At a 
10-month follow-up, the patient’s general condition 
was satisfactory and TTE indicated no thrombus 
recurrence. However, prednisolone was continued 
indefinitely due to recurrent eye involvement. 
Warfarin was also continued due to prolonged bedrest 
caused by haemiparesis which increases the risk of 
thromboemboli in the extremities.
Discussion
This report presents a patient with Behçet’s disease 
with right ventricle thrombus formation after a 
previous cerebral artery aneurysm rupture. Cardiac in-
volvement in Behçet’s disease is very rare and consists 
mainly of thrombus formation. While any chamber of 
the heart may be involved in clot formation, the right 
atrium, with its unique haemodynamic characteristics, 
is the most commonly affected chamber.5 All of the 
layers of the heart are involved in the inflammatory 
process of Behçet’s disease.6 Endothelial inflammation 
can cause luminal irregularities and thickening which 
is revealed as thrombi, Loeffler endocarditis and 
arterial aneurysm formation. Thrombi of the superior 
and inferior vena cava (IVC) may cause superior vena 
cava syndrome and Budd-Chiari syndrome. Systemic 
lupus erythematosus (SLE) can be associated with 
cardiac thrombosis and cerebral complications;6 ruling 
out SLE as a diagnosis was therefore necessary in the 
current case.
Aneurysms of the large and medium arteries—
such as the aorta, pulmonary and peripheral arteries 
including the femoral, popliteal, brachial and 
subclavian arteries—can form part of the vascular 
involvement in Behçet’s disease.6 One important 
medium-sized artery involved in aneurysm formation 
is the cerebral artery. Although vascular inflammatory 
disease is observed in only 25% of patients with 
Behçet’s disease, it is nonetheless the most important 
predictive factor of Behçet’s disease-related mortality.6 
The combination of cerebral and cardiac manifest-
ations of Behçet’s disease is a very uncommon 
phenomenon.7 Intracardiac thrombus formation may 
be caused by cardiac endothelial inflammation or may 
arise from an extracardiac thrombus that has broken 
off from the thromboembolism source in a peripheral 
vein and dislodged into the cardiac chamber. However, 
emboli that originate from a cardiac chamber are a 
relatively uncommon occurrence.7 
Mogulkoç et al. detected 13 cases of pulmonary 
emboli among 25 subjects with Behçet’s disease; 
in approximately 50% of these cases, thrombosis in 
the inferior and superior vena cavae and deep lower 
extremity veins may have been the source of the 
embolism.5 Most emboli in Behçet’s disease patients 
begin in the cardiac chambers.8 In patients without 
Behçet’s disease, deep vein thrombosis in the lower 
extremities is usually associated with pulmonary 
emboli, as thrombi formed in the veins in the absence 
of inflammation can easily break off and travel 
to the heart and lungs. Contrary to conventional 
thromboemboli, the combination of a pulmonary 
thromboembolism with lower extremity phlebitis 
is a rare event in patients with Behçet’s disease.8 
Thrombi formed in inflamed vessels are strongly 
adherent to the endothelium; therefore, these patients 
have a low risk of thromboembolism.9,10 Houman et 
al. observed vascular involvement in 43.3% of 113 
Behçet’s disease cases; of those, 89.8% had deep vein 
thrombosis.11 Involvement of the deep venous system 
is more common in men than women.10 Luo et al. 
evaluated the clinical features of patients with Behçet’s 
disease and cardiac chamber thrombi; they found that 
intracardiac thrombus formation frequently occurred 
in young male patients and usually involved the right 
cardiac chambers.12 
In the present case report, the patient was treated 
with immunosuppressive and antithrombotic drugs 
following the surgical removal of the cardiac thrombus. 
 
Figure 4: Intraoperative photograph of a thrombus in 
the right ventricular outflow tract of the subtricuspid 
apparatus (arrow) of a 35-year-old female with Behçet’s 
disease.
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metabolomic evaluation of Behcet’s disease with arthritis and 
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doi: 10.1159/000435804.
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thrombosis: A report of three cases. Case Rep Rheumatol 2013; 
2013:637015. doi: 10.1155/2013/637015.
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10. Joo HJ, Hong SJ, Yu CW. Transcatheter aortic valve-in-valve 
implantation for severe bioprosthetic stenosis after Bentall 
operation using a homograft in a patient with Behçet’s disease. 
J Heart Valve Dis 2015; 24:217–19.
11. Houman MH, Ben Ghorbel I, Khiari Ben Salah I, Lamloum M, 
Ben Ahmed M, Miled M. Deep vein thrombosis in Behçet’s 
disease. Clin Exp Rheumatol 2001; 19:S48–50.
12. Luo L, Ge Y, Liu ZY, Liu YT, Li TS. [A report of eight cases 
of Behcet’s disease with intracardiac thrombus and literatures 
review]. Zhonghua Nei Ke Za Zhi 2011; 50:914–17. 
Cyclophosphamide, azathioprine and prednisolone 
were prescribed. Prior to starting treatment with 
cyclophosphamide and azathioprine, routine baseline 
assessments were performed, including a complete 
blood cell count and liver and renal function tests; 
regular monitoring continued throughout treatment. 
To prevent urinary toxicity such as haemorrhagic 
cystitis, patients need to be adequately hydrated 
and pass urine frequently. As such, patients should 
be instructed to increase their fluid intake 24 hours 
before, during and at least 24 hours after receiving 
cyclophosphamide.12 
Conclusion
In the present case, a large intracardiac thrombus was 
detected in a patient with Behçet’s disease who had 
previously undergone neurosurgery for a ruptured 
cerebral artery aneurysm. The patient underwent open-
heart surgery for the removal of the thrombus before 
undergoing immune suppression and antithombotic 
therapy. At a 10-month follow-up, she was healthy 
with no evidence of further thrombus formation.
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